Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email


>> PFIZER Latest News

JAN 15, 2013 - Forbes

A Must Read - Share

By Hinting At Breakup, Pfizer Controls Wall Street Conversation

How much does a Pfizer executive have to say in order to get Wall Street analysts talking about the odds that the company will split itself in two? About a dozen. See this Bloomberg story: Pfizer’s business units cover oncology, primary care, specialty drugs, and so-called established products, which are medicines that have lost patent protection and are sold against generics. That’s “probably going to evolve to two, where there’s the innovative business and the value business,” Geno Germano, president of the specialty care and oncology businesses, said in an interview.

Tags: By Hinting At Breakup, Pfizer Controls Wall Street Conversation,  Pfizer Latest News